Managing Director & Partner
Basir joined the Frankfurt office of The Boston Consulting Group in April 2007. He is a member of BCG's Marketing, Sales & Pricing (MSP) practice.
Within the MSP practice, Basir focuses on digital go-to-market with deep experience in omni-channel, eCommerce, eEnabled Sales, next-generation sales, digital marketing, and digital transformation. Basir serves international clients across various industries, with a focus on consumer goods, industrial goods, health care, and TMT.
Prior to joining BCG, Basir worked for IBM and in the startup space in the Silicon Valley.
The era of the “road warrior” sales rep is over. Companies can sell far more efficiently through a hybrid of in-person and digital interactions with customers.
A next-generation commercial model is needed fast. Those who adopt it quickly will be rewarded handsomely.
Advanced digital and data competencies—combined with human interaction and engagement—are indispensable to creating and scaling the high-quality B2B buying experiences that customers expect.
BCG's Basir Mustaghni explains how marketing organizations are disrupted by the arrival of new digital channels.
RevOps is a high-impact way to accelerate growth and efficiency through tighter alignment of your marketing, sales, and customer success functions.
To win in B2B markets, companies must expand the scope of account-based marketing to cover hundreds, even thousands, of target customers. The challenge with that kind of ABE is getting marketing, sales, and service to work together. Here’s how ABE leaders are succeeding.
Executives in B2B markets must take four steps to stabilize and increase sales in these turbulent times: respond, reflect, reimagine, and rebound.
Centralizing demand generation and lead management is a good strategy, but don’t underestimate its potential to transform your go-to-market approach and support capabilities.
B2B companies need to transform the way they engage customers, use data and technology, structure their organizations, and acquire new skills.